Prognostic factors in childhood vitiligo

• Published in: Boletin medico del Hospital Infantil de Mexico Vol. 81; no. 2; p. 73
• Main Authors: Villegas-Calzada, M Fernanda, Acatitla-Acevedo, Graciela A, Anda-Ortiz, Nabil De, Morales-Sánchez, Martha A
• Format: Journal Article
• Language: English; Spanish
• Published: Mexico 2024
• Subjects: Adolescent; Age of Onset; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Humans; Infant; Male; Prognosis; Retrospective Studies; Thyroid Diseases - epidemiology; Thyroid Diseases - pathology; Vitiligo - diagnosis; Vitiligo - epidemiology; Vitiligo - pathology; Vitiligo; Autoimmune disorder; Trastorno autoinmunitario; Infancia; Childhood; Factores pronósticos; Prognostic factors
• ISSN: 1665-1146
• DOI: 10.24875/BMHIM.23000083

Vitiligo is a multifactorial disease characterized by the progressive loss of melanocytes. The worldwide prevalence ranges from 0.5% to 2%, and in children from 0% to 2.16%. The objective of this study was to determine the variables associated with progression of vitiligo.
A retrospective cohort was carried out where a random sample of records of pediatric patients with vitiligo from January 2016 to December 2020 was analyzed. The variables were studied: age at onset, sex, hereditary family history, personal history of thyroid diseases, time of evolution, classification, Köebner phenomena, mucosal vitiligo, halo nevus, premature graying and the presence of other dermatoses. The final state was classified as progression, stability, partial remission and complete remission.
574 children with vitiligo; 290 (50.5%) women, 284 (49.5%) men. Non-segmental vitiligo in 324 (56.4%), segmental vitiligo in 250 (43.6%). Mean age of onset 8.7 years (SD: 4.54). Median evolution time 6 months (25
percentile of 3 months and 75
percentile of 24 months). Family history 27 (4.70%). Thyroid disease 7 (1.21%). Evolution remained stable in 44 (7.7%), 68 (11.8%) had progression, 32 (5.6%) complete remission, 222 (38.7%) partial remission and 208 (36.2%) one consultation. Non-segmental vitiligo was obtained p < 0.028, younger age of onset p < 0.000, and none skin comorbidities p < 0.009.
The variables that were associated with a more progression were non-segmental vitiligo, early ages at the onset of the disease, and not presenting with other skin diseases.